Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter

NCT01270152 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Occluded Totally Implanted Central Venous Catheter

Interventions

DRUG: Ascorbic Acid

Sponsor

University of Sao Paulo